Literature DB >> 28628281

Genomic analysis of melanoma evolution following a 30-year disease-free interval.

Jerry J Miller1, Kristopher A Lofgren2, Sarah R Hughes3, Steven E Cash2, Paraic A Kenny2,4.   

Abstract

Ultra-late melanoma recurrence is infrequent, poorly understood and, in most cases, difficult to unambiguously distinguish from a new primary melanoma. We identified a patient with a second melanoma diagnosed after a 30-year disease-free interval, and sought to determine if this new lesion was a recurrence of the original melanoma. Here we report the genomic sequence analysis of the exomes of 2 melanoma lesions isolated from the same individual in 1985 and 2015, and their comparison to each other and to the germline DNA of the patient. Identification of many shared somatic mutations between these lesions proves a lineal relationship spanning 30 years. Unlike prior reports of ultra-late melanoma recurrence, the availability of the original tumor and the use of comprehensive genomic analysis allowed us to confirm that the second lesion is truly a recurrence. We demonstrate the acquisition of numerous additional mutations during the 3 decade asymptomatic period. These data highlight the low but very long-lasting risk of recurrence in this patient population.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  exome sequencing; melanoma; recurrence; tumor evolution

Mesh:

Year:  2017        PMID: 28628281     DOI: 10.1111/cup.12989

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  2 in total

1.  Accumulation of CD103+ CD8+ T cells in a cutaneous melanoma micrometastasis.

Authors:  Katharina Hochheiser; Han Xian Aw Yeang; Teagan Wagner; Candani Tutuka; Andreas Behren; Jason Waithman; Christopher Angel; Paul J Neeson; Thomas Gebhardt; David E Gyorki
Journal:  Clin Transl Immunology       Date:  2019-12-25

2.  Late Metastatic Melanoma after 25 Years: A Case Report and a Brief Literature Review.

Authors:  Elena Pescarini; Gabriela Spanikova; Zacharia Mbaidjol; Eleonora De Antoni; Vincenzo Vindigni; Franco Bassetto
Journal:  Case Rep Surg       Date:  2020-10-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.